https://biotechmorning.com/news/osteosarcoma-hansoh-b7h3-adc-phase-3-win Biotech Morning en 2026-08-04T14:26:37.098Z The Bone Cancer That Broke Every Drug for 40 Years Just Met Its Match https://biotechmorning.com/news/gsk-alector-neurodegeneration-deal-collapse Biotech Morning en 2026-08-04T14:25:49.717Z GSK Just Lit $700 Million on Fire (and Walked Away) https://biotechmorning.com/news/curium-lantheus-8-billion-radiopharmaceutical-megadeal Biotech Morning en 2026-08-04T14:24:58.777Z The $8 Billion Bet That Nuclear Medicine Is the Future of Cancer Care https://biotechmorning.com/news/biontech-sahin-steps-down-oelkers-ceo Biotech Morning en 2026-08-04T14:24:06.943Z BioNTech Just Lost the Scientist Who Saved the World https://biotechmorning.com/news/haya-lncrna-heart-drug-fda-fast-track Biotech Morning en 2026-08-04T14:23:13.564Z The Heart Drug Built From DNA's 'Dark Side' https://biotechmorning.com/news/wave-life-sciences-wve-007-obesity-fat-spares-muscle Biotech Morning en 2026-08-04T14:22:24.564Z An Obesity Drug That Burns Fat and Spares Muscle? Wave Just Started Testing It https://biotechmorning.com/news/amgen-corlanor-recall-million-bottles Biotech Morning en 2026-08-04T14:21:20.502Z A Million Bottles of Heart Pills Just Got Pulled From Shelves https://biotechmorning.com/news/sandoz-450-million-generic-drug-price-fixing-settlement Biotech Morning en 2026-08-04T14:20:28.697Z The $450 Million Check Sandoz Hopes Will Make Its Biggest Headache Disappear https://biotechmorning.com/news/nih-budget-cut-biotech-pipeline-threat Biotech Morning en 2026-08-04T14:19:42.036Z The NIH Just Got a Haircut That Could Leave Biotech Bald https://biotechmorning.com/news/supernus-indivior-cns-merger Biotech Morning en 2026-08-04T14:18:48.794Z Two CNS Pharma Companies Just Stitched Themselves Together. Here's Why. https://biotechmorning.com/news/wainua-attr-cardiomyopathy-phase-3-failure Biotech Morning en 2026-08-04T14:17:51.850Z The Heart Drug That Worked Everywhere Except the Heart https://biotechmorning.com/news/astrazeneca-ionis-attr-cm-phase-3-failure Biotech Morning en 2026-08-03T14:24:07.244Z The $30 Billion Wipeout That Started With a Bad Test Design https://biotechmorning.com/news/jj-sail-biomedicines-in-vivo-car-t-deal Biotech Morning en 2026-08-03T14:23:10.235Z J&J Just Put $2.58 Billion on a CAR-T Therapy That Doesn't Exist Yet https://biotechmorning.com/news/astrazeneca-bms-megamerger-talks Biotech Morning en 2026-08-03T14:22:16.211Z The $400 Billion Pharma Marriage Nobody Asked For https://biotechmorning.com/news/weight-loss-drug-aced-alcohol-addiction-trial Biotech Morning en 2026-08-03T14:21:24.289Z A Weight-Loss Drug Just Aced an Alcohol Addiction Trial https://biotechmorning.com/news/moderna-mrna-flu-vaccine-fda-decision Biotech Morning en 2026-08-03T14:20:33.247Z The Flu Shot Hasn't Changed in Decades. That Might End Tuesday. https://biotechmorning.com/news/arpa-h-160-million-gene-editing-thrive-program Biotech Morning en 2026-08-03T14:19:40.505Z The $160 Million Bet That Could Turn One-Patient Miracles Into a Playbook https://biotechmorning.com/news/replimune-rp1-fda-rejection-melanoma-stock-crash Biotech Morning en 2026-08-03T14:18:50.013Z The Virus That Couldn't Catch a Break https://biotechmorning.com/news/elevidys-gene-therapy-liver-failure-deaths-fda-investigation Biotech Morning en 2026-08-03T14:17:55.195Z The Gene Therapy That Saved Kids' Muscles May Be Destroying Their Livers